NasdaqGS - Nasdaq Real Time Price USD

Nautilus Biotechnology, Inc. (NAUT)

2.4900 +0.1300 (+5.51%)
At close: 4:00 PM EDT
2.4600 -0.03 (-1.20%)
After hours: 5:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
76,152.0000
76,152.0000
63,618.0000
50,498.0000
15,744.0000
Operating Income
-76,152.0000
-76,152.0000
-63,618.0000
-50,498.0000
-15,744.0000
Net Non Operating Interest Income Expense
12,550.0000
12,550.0000
5,816.0000
329.0000
--
Other Income Expense
-73.0000
-73.0000
-122.0000
-146.0000
125.0000
Pretax Income
-63,675.0000
-63,675.0000
-57,924.0000
-50,315.0000
-15,619.0000
Net Income Common Stockholders
-63,675.0000
-63,675.0000
-57,924.0000
-50,315.0000
-15,619.0000
Diluted NI Available to Com Stockholders
-63,675.0000
-63,675.0000
-57,924.0000
-50,315.0000
-15,619.0000
Basic EPS
-0.51
--
-0.46
-0.60
-0.13
Diluted EPS
-0.51
--
-0.46
-0.60
-0.13
Basic Average Shares
124,919.1440
--
124,589.5550
84,464.0810
124,045.2550
Diluted Average Shares
124,919.1440
--
124,589.5550
84,464.0810
124,045.2550
Total Expenses
76,152.0000
76,152.0000
63,618.0000
50,498.0000
15,744.0000
Net Income from Continuing & Discontinued Operation
-63,675.0000
-63,675.0000
-57,924.0000
-50,315.0000
-15,619.0000
Normalized Income
-63,675.0000
-63,675.0000
-57,924.0000
-50,315.0000
-15,619.0000
Interest Income
12,550.0000
12,550.0000
5,816.0000
329.0000
--
Net Interest Income
12,550.0000
12,550.0000
5,816.0000
329.0000
--
EBIT
-76,152.0000
-76,152.0000
-63,618.0000
-50,498.0000
-15,744.0000
EBITDA
-70,447.0000
-70,447.0000
-60,202.0000
-47,656.0000
-13,398.0000
Reconciled Depreciation
5,705.0000
5,705.0000
3,416.0000
2,842.0000
2,346.0000
Net Income from Continuing Operation Net Minority Interest
-63,675.0000
-63,675.0000
-57,924.0000
-50,315.0000
-15,619.0000
Normalized EBITDA
-70,447.0000
-70,447.0000
-60,202.0000
-47,656.0000
-13,398.0000
12/31/2020 - 8/7/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SEER Seer, Inc.
1.9100
+9.14%
 
QSI Quantum-Si incorporated
1.6500
+2.48%
 
SCPH scPharmaceuticals Inc.
4.4900
+3.22%
 
LYRA Lyra Therapeutics, Inc.
4.7200
-8.70%
 
RPHM Reneo Pharmaceuticals, Inc.
1.6700
+1.21%
 
LBPH Longboard Pharmaceuticals, Inc.
19.72
+2.44%
 
MORF Morphic Holding, Inc.
28.07
+0.32%
 
IOBT IO Biotech, Inc.
1.4200
-2.07%
 
MURA Mural Oncology plc
3.5800
+1.42%
 
PEPG PepGen Inc.
11.93
+1.97%